Collaborative Assessment and Management of Suicidality (CAMS) compared to treatment as usual (TAU) for suicidal patients: Study protocol for a randomized controlled trial

Trials

Volumn 17, Issue 1, 2016, Pages

  Ryberg, Wenche ^a   Fosse, Roar ^a   Zahl, Per Henrik ^b   Brorson, Inge ^c   Møller, Paul ^a   Landrø, Nils Inge ^d   Jobes, David ^e  

^a VESTRE VIKEN HOSPITAL TRUST   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c Blue Cross Addiction Clinic   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e CATHOLIC UNIVERSITY OF AMERICA   (United States)

Author keywords

Collaborative approach; Pragmatic randomized controlled trial; Suicidal patients; Treatment

Indexed keywords

ADULT; ARTICLE; BECK SCALE FOR SUICIDE IDEATION CURRENT; COLLABORATIVE ASSESSMENT AND MANAGEMENT OF SUICIDALITY; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; INTERVENTION STUDY; INTERVIEW; MAJOR CLINICAL STUDY; MENTAL HEALTH CARE; NORWAY; OUTCOME QUESTIONNAIRE 45; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SUICIDAL IDEATION; SUICIDE ATTEMPT; SUICIDE ATTEMPT SELF INJURY COUNT; TREATMENT AS USUAL; TREATMENT DURATION; CHECKLIST; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITION; COOPERATION; INTERDISCIPLINARY COMMUNICATION; MENTAL HEALTH; METHODOLOGY; MULTICENTER STUDY; PATIENT CARE; PROCEDURES; PSYCHOLOGY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SUICIDE; TIME FACTOR; TREATMENT OUTCOME;

CHECKLIST; CLINICAL PROTOCOLS; COGNITION; COOPERATIVE BEHAVIOR; HUMANS; INTERDISCIPLINARY COMMUNICATION; MENTAL HEALTH; NORWAY; PATIENT CARE TEAM; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; RESEARCH DESIGN; RISK FACTORS; SUICIDAL IDEATION; SUICIDE; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84989323195     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1602-z     Document Type: Article

References (54)

1. WHO. Preventing suicide: a global imperative. Luxembourg: World Health Organisation; 2014.
2. The Norwegian Directorate of Health and Social Affairs. National guidelines for the prevention of suicide in mental health care. Oslo: Norwegian Directorate of Health and Social Affairs; 2008.
3. Norwegian Institute of Public Health. Causes of death and life expectancy. 2015. http://statistikkbank.fhi.no/dar/. Accessed 3 July 2016.
4. Judd F, et al. The profile of suicide: changing or changeable? Soc Psychiatry Psychiatr Epidemiol. 2012;47(1):1-9.
5. Cavanagh JT, et al. Psychological autopsy studies of suicide: a systematic review. Psychol Med. 2003;33(3):395-405.
6. Mellesdal L, et al. Suicide risk and acute psychiatric readmissions: a prospective cohort study. Psychiatr Serv. 2010;61(1):25-31.
7. Ruud T, Gråwe Rolf W, Trond H. Akuttpsykiatrisk behandling i Norge- resultater fra en multisenterstudie. Oslo: Sintef Helse; 2006. p. 1-148.
8. Qin P, Nordentoft M. Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers. Arch Gen Psychiatry. 2005;62(4):427-32.
9. Comtois KA, Linehan MM. Psychosocial treatments of suicidal behaviors: a practice-friendly review. J Clin Psychol. 2006;62(2):161-70.
10. Ellis TE, et al. Implementing an evidence-based approach to working with suicidal inpatients. Bull Menninger Clin. 2009;73(4):339-54.
11. Linehan MM, et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006;63(7):757-66.
12. Brown GK, et al. Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial. JAMA. 2005;294(5):563-70.
13. Rudd MD, et al. Brief cognitive-behavioral therapy effects on post-treatment suicide attempts in a military sample: results of a randomized clinical trial with 2-year follow-up. Am J Psychiatry. 2015;172(5):441-9.
14. Jobes DA, Au JS, Siegelman A. Psychological approaches to suicide treatment and prevention. Curr Treat Options Psychiatry. 2015;2(4):363-70.
15. Jobes DA. Managing suicidal risk: a collaborative approach. New York: Guilford Press; 2006.
16. Andreasson K, et al. Effectiveness of dialectical behavior therapy versus collaborative assessment and management of suicidality treatment for reduction of self-harm in adults with borderline personality traits and disorder-a randomized observer-blinded clinical trial. Depress Anxiety. 2016;33(6):520-30.
17. Jobes DA. The Collaborative Assessment and Management of Suicidality (CAMS): an evolving evidence-based clinical approach to suicidal risk. Suicide Life Threat Behav. 2012;42(6):640-53.
18. Comtois KA, et al. Collaborative Assessment and Management of Suicidality (CAMS): feasibility trial for next-day appointment services. Depress Anxiety. 2011;28(11):963-72.
19. Ness E, et al. All suicides are not due to treatment failure. Tidsskr Nor Laegeforen. 2015;135(15):1342-3.
20. Hagen J, Hjelmeland H, Knizek BL. Excessive belief in suicide risk assessments? Tidsskr Nor Laegeforen. 2014;134(4):394.
21. Jobes DA, Comtois KA, Brenner LA, Gutierrez PM, O'Connor S. Lessons learned from clinical trials of the Collaborative Assessment and Management of Suicidality (CAMS). In: O'Connor RC, Pirkis J, editors. International handbook of suicide prevention: research, policy, and practice. 2nd ed. West Sussex: Wiley-Blackwell; 2016.
22. Ellis TE, et al. Impact of a suicide-specific intervention within inpatient psychiatric care: The Collaborative Assessment and Management of Suicidality. Suicide Life Threat Behav. 2015. doi:10.1111/sltb.12151.
23. Arkov K, et al. Treatment of suicidal patients: the Collaborative Assessment and Management of Suicidality. Ugeskr Laeger. 2008;170(3):149-53.
24. Ellis TE, et al. Collaborative Assessment and Management of Suicidality in an inpatient setting: results of a pilot study. Psychotherapy (Chic). 2012;49(1):72-80.
25. Nielsen AC, Alberdi F, Rosenbaum B. Collaborative assessment and management of suicidality method shows effect. Dan Med Bull. 2011;58(8):A4300.
26. Andreasson K, et al. The DiaS trial: dialectical behavior therapy versus collaborative assessment and management of suicidality on self-harm in patients with a recent suicide attempt and borderline personality disorder traits - study protocol for a randomized controlled trial. Trials. 2014;15:194. doi: 10.1186/1745-6215-15-194.
27. Beck AT, Brown GK, Steer RA. Psychometric characteristics of the Scale for Suicide Ideation with psychiatric outpatients. Behav Res Ther. 1997;35(11):1039-46.
28. Maruish ME. Psychological testing in the age of managed behavioral health care. Mahwah: Lawrence Erlbaum Associates; 2002. p. xi. 350 s.
29. Amble I, et al. Psychometric properties of the outcome questionnaire-45.2: the Norwegian version in an international context. Psychother Res. 2014;24(4):504-13.
30. Sheehan DV, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33. quiz 34-57.
31. First MB. User's guide for the structured clinical interview for DSM-IV axis II personality disorders: SCID-II. Washington, DC: American Psychiatric Press; 1997.
32. Schwarzer R. Measurement of perceived self-efficacy: psychometric scales for crosscultural research. Forschung an der Freien Universität Berlin. Berlin: Freie Universität Berlin; 1993. p. 45.
33. Luszczynska A, Scholz U, Schwarzer R. The general self-efficacy scale: multicultural validation studies. J Psychol. 2005;139(5):439-57.
34. Hatcher RL, Gillaspy JA. Development and validation of a revised short version of the working alliance inventory. Psychother Res. 2006;16(1):12-25.
35. Saunders JB, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993;88(6):791-804.
36. Berman AH, et al. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005;11(1):22-31.
37. Nesvag R, et al. The use of screening instruments for detecting alcohol and other drug use disorders in first-episode psychosis. Psychiatry Res. 2010;177(1-2):228-34.
38. Voluse AC, et al. Psychometric properties of the Drug Use Disorders Identification Test (DUDIT) with substance abusers in outpatient and residential treatment. Addict Behav. 2012;37(1):36-41.
39. Jobes DA, et al. Assessment and treatment of suicidal clients in a university counseling center. J Couns Psychol. 1997;44(4):368-77.
40. Conrad AK, et al. A psychometric investigation of the Suicide Status Form II with a psychiatric inpatient sample. Suicide Life Threat Behav. 2009;39(3):307-20.
41. The Norwegian Directory of Health. The Norwegian patient safety programme: in safe hands. 2016. http://www.pasientsikkerhetsprogrammet.no/no/I+trygge+hender. Accessed 29 Aug 2016.
42. Crowley KJ, Arnkoff DB, Glass CR, Jobes DA. Collaborative assessment and management of suicidality (CAMS): adherence to a flexible clinical framework. In: Crumlish, editor. The collaborative assessment and management of suicidality: perspectives from the Catholic University suicide prevention lab. Los Angeles: American Association of Suicidology; 2014.
43. Sterne JA, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.
44. Fonagy P, et al. What works for whom? A critical review of treatments for children and adolescents. 2nd ed. New York: Guilford Press; 2015. p. XVI. 639 s.
45. Cochrane AL. Effectiveness and efficiency: random reflections on health services. The Rock Carling Fellowship. London: The Nuffield Provincial Hospitals Trust; 1972. p. xi. 92.
46. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet. 2005;365(9453):82-93.
47. Shean GD. Some limitations on the external validity of psychotherapy efficacy studies and suggestions for future research. Am J Psychother. 2012;66(3):227-42.
48. Treweek S, Zwarenstein M. Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials. 2009;10:37.
49. Zwarenstein M, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390.
50. Ross S, et al. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999;52(12):1143-56.
51. Howard L, et al. Why is recruitment to trials difficult? An investigation into recruitment difficulties in an RCT of supported employment in patients with severe mental illness. Contemp Clin Trials. 2009;30(1):40-6.
52. Law MK, et al. Does assessing suicidality frequently and repeatedly cause harm? A randomized control study. Psychol Assess. 2015;27(4):1171-81.
53. Pokorny AD. Prediction of suicide in psychiatric patients. Report of a prospective study. Arch Gen Psychiatry. 1983;40(3):249-57.
54. Beck AT, et al. Suicide ideation at its worst point: a predictor of eventual suicide in psychiatric outpatients. Suicide Life Threat Behav. 1999;29(1):1-9.